Topic: Structural Heart

Dive Brief: Rural hospitals were less likely to be eligible to start a transcatheter aortic […]

Endologix today said it received FDA approval for its Alto Abdominal Stent Graft System. The […]

Dive Brief: Keystone Heart, a unit of China’s Venus Medtech, said Tuesday it received a […]

CryoLife, Inc., a company based outside of Atlanta, Georgia, announced this week that it has […]

Dive Brief: Healthcare professionals have voiced support for Abbott’s request for CMS to stop using […]

CryoLife Inc. (NYSE:CRY) announced that it received CE Mark approval for the On-X ascending aortic prosthesis (AAP) for […]

A variety of congenital cardiac abnormalities require the placement of prosthetic heart valves in very […]

Dive Brief: A research letter and editorial published online Monday in JAMA Internal Medicine renews […]

Cardiovalve (Or Yehuda, Israel) said today that U.S. FDA has granted a breakthrough device designation for […]

Dive Brief: Teleflex has struck a $260 million deal to buy IWG High Performance Conductors […]

Boston Children’s Hospital is touting a new design that could allow children to maintain the […]

Dive Brief: Awaiting a Medicare reimbursement decision any day for its MitraClip transcatheter mitral valve […]

Just starting to learn about all of the medical devices out there for treating cardiovascular […]

JenaValve Technology announced that it raised $50 million in equity financing as it develops and manufactures […]

Heart valve maker JenaValve Technology has raised $50 million in new venture capital funding, not […]

Aria CV announced that it won FDA breakthrough device designation for its pulmonary hypertension (PH) system […]

BioVentrix has received the renewal of the highest priority reimbursement in Germany for its transcatheter […]

Abbott (NYSE:ABT) announced today that it won FDA breakthrough device designation for its in-development fully implantable […]

Lately, it seems as if Abbott Laboratories has been extremely busy building its structural heart […]

  Massachusetts Institute of Technology announced that engineers at the institute, along with others elsewhere, […]

Dive Brief: Edwards Lifesciences’ nearly 20% year-over-year revenue growth topped Wall Street’s fourth quarter revenue […]

Abbott just announced that it is the first company to receive European regulatory approval to […]

A five-year study by Edwards Lifesciences demonstrated no significant differences in the number of deaths […]

Dive Brief: Abbott said Thursday it won the first EU approval for a transcatheter mitral […]

Dive Brief: Five years after undergoing aortic valve replacement, intermediate-risk patients who received an Edwards […]

Edwards Lifesciences (NYSE:EW) shares are recovering a bit today — a day after the stock took […]

Dive Brief: Moody’s Investors Service expects revenues from cardiology technologies to outperform the wider medtech […]

Teleflex (NYSE:TFX) announced today that it won FDA 510(k) clearance for its Wattson temporary pacing guidewire […]

Dive Brief: Longtime Abbott CEO Miles White’s final earnings call (the “85th or 86th” of […]

The leading transcatheter heart valve medical device player in China – Venus Medtech (Hangzhou) Inc. (“Venus Medtech” or the […]

Mayo uses the Da Vinci surgical robot to perform minimally invasive mitral valve surgeries to intervene earlier […]

Dive Brief: A study published in JAMA Cardiology on Wednesday​ of Abbott’s left ventricular assist device (LVAD) […]

After reporting a fourth-quarter revenue shortfall due to a slowdown in its cardiac rhythm management […]

ABBOTT PARK, Ill., Jan. 13, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the U.S. Food and Drug […]

JenaValve Technology said today that FDA has granted breakthrough device designation for its JenaValve Pericardial TAVR. […]

With strong leadership and a taste for risk-taking, outgoing CEO Miles White left no stone […]

JenaValve is showing significant progress in the plan to get its transcatheter aortic valve replacement […]

Neovasc (NSDQ:NVCN) announced that has it closed its previously announced registered direct offering for aggregate gross […]

Abbott (NYSE:ABT) today announced that FDA has approved implantation of its HeartMate 3 LVAD via lateral […]